Abogen Biosciences is a fully integrated new powerhouse in the evolving field of mRNA-based therapeutics. Driven by the mission to revolutionize the future of health and life, we are committed to pioneering mRNA medicine through innovation, integration and insight.
Founded in 2019, we have been rapidly rising to prominence in biotechnology powered by our proprietary clinically validated mRNA-LNP platform that combines advanced AI technologies, automation and scalable manufacturing. With deep expertise in mRNA modifications and delivery, we are pushing the boundaries of immuno-oncology, autoimmune and infectious disease treatments.
At the crossroads of science, technology and healthcare, we aspire to deliver transformative medicines through mRNA innovations, turning the impossible into reality.
Company Details
- Employees
- 81
- Founded
- -
- Address
- Building 8, Lane 21, Dongyanli Road, Suzhou Industrial Park, Suzhou,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.abogenbio.com/
- Keywords
- in mRNA modifications and delivery.
- HQ
- Suzhou
Abogen Biosciences Questions
Abogen Biosciences's website is http://www.abogenbio.com/
Abogen Biosciences's LinkedIn profile is https://cn.linkedin.com/company/abogenbiosciences
Abogen Biosciences has
81 employees.
View email and phone details for 81
employees at Abogen Biosciences.
Abogen Biosciences's industry is
Biotechnology Research
Abogen Biosciences's top competitors are
Ascentage Pharma,
Zelgen Biopharmaceuticals,
Legend Biotech,
Hengrui Pharma,
Arcturus Therapeutics,
Byterna Therapeutics,
Replicate Bioscience, Inc.,
Nchroma Bio,
Nutcracker Therapeutics,
Abogen, Inc..
Abogen Biosciences's categories are Biotechnology Research
Abogen Biosciences's founding year is 2019
